News & Blog
May 9, 2018
Tyler Bartholomew is a doctoral student in the Department of Public Health Sciences at the University of Miami. Prior to entering the doctoral program, he was the project manager for an HIV and HCV testing, linkage to care, and treatment program at five federally-qualified health centers in Philadelphia, Pennsylvania as part of his AmeriCorps service. […]
[cross-posted from Health Policy$ense, the blog of the Leonard Davis Institute of Health Economics. This blog includes research led by CHERISH Research Affiliate Marcus Bachhuber, as well as LDI Senior Fellow and CHERISH Investigator Dan Polsky and CHERISH investigator Sean Murphy.] Last month, the American Dental Association (ADA) announced a new policy on opioid […]
Between 1999 and 2015, the annual sales of opioid analgesics in the US quadrupled to about $8 billion dollars. In an effort to address over-prescribing of opioid analgesics, Dr. Marcus Bachhuber recently received a career development award (K-award) from the National Institute on Drug Abuse (NIDA) to implement a default opioid prescribing system in the […]
On March 19, researchers from institutions across the country joined CHERISH leaders Bruce Schackman, Kathryn McCollister, Benjamin Linas and Sean Murphy for a daylong CHERISH introductory training to economic evaluations. Dr. Schackman began the day by introducing CHERISH to the attendees, who represented more than 25 institutions across New England, the Midwest, the Mid-Atlantic, the South […]
February 27, 2018
Hepatitis C Virus (HCV) is one of the leading causes of infectious disease deaths in the United States. Injection drug use is a common route of HCV transmission and the annual number of reported cases continues to rise due to the opioid epidemic. Previous HCV treatment regimens had severe side effects and limited efficacy, but […]
Is it possible that the widespread prescribing of excessive amounts of opioids for C-section and knee arthroscopy patients is responsible for producing a significant number of opioid dependencies? That question is the subject of Perelman School of Medicine postdoctoral researcher Benjamin Ukert‘s new pilot project funded by the Center for Health Economics of Treatment Interventions for Substance Use Disorder, […]